Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001310976 | SCV001500981 | pathogenic | not provided | 2020-11-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001869220 | SCV002217170 | pathogenic | Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S | 2024-01-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg788*) in the IGHMBP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IGHMBP2 are known to be pathogenic (PMID: 14681881, 25439726, 25568292). This variant is present in population databases (rs199839840, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with spinal muscular atrophy with respiratory distress type 1 (PMID: 14681881, 20859832, 23449687, 29761130). ClinVar contains an entry for this variant (Variation ID: 637262). For these reasons, this variant has been classified as Pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252236 | SCV002523243 | likely pathogenic | See cases | 2019-09-17 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PM2 |
Gene |
RCV001310976 | SCV002577193 | pathogenic | not provided | 2022-09-29 | criteria provided, single submitter | clinical testing | Identified in the presence of a second IGHMBP2 variant, phase unknown, in patients with clinical features consistent with SMARD1 in the published literature (Grohmann et al., 2003; Chiu et al., 2018); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21827898, 15248100, 26354092, 20859832, 25525159, 14681881, 32028661, 29761130) |
Revvity Omics, |
RCV001310976 | SCV003818321 | pathogenic | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing | |
Inherited Neuropathy Consortium | RCV000789336 | SCV000928689 | uncertain significance | Neuronopathy, distal hereditary motor, autosomal dominant | no assertion criteria provided | literature only | ||
Genesis Genome Database | RCV000856977 | SCV000999544 | uncertain significance | Charcot-Marie-Tooth disease | 2019-08-14 | no assertion criteria provided | research | |
Biochemical Molecular Genetic Laboratory, |
RCV000985181 | SCV001133196 | likely pathogenic | Autosomal recessive distal spinal muscular atrophy 1 | 2019-09-26 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV001310976 | SCV001917089 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001310976 | SCV001959864 | pathogenic | not provided | no assertion criteria provided | clinical testing |